Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 3,861 | 6,000 | 5,444 | 5,150 | 4,542 |
| Cost of Goods | 2,154 | 2,897 | 2,883 | 2,732 | 2,468 |
| Gross Profit | 1,707 | 3,103 | 2,561 | 2,419 | 2,074 |
| Operating Expenses | 2,480 | 3,429 | 3,298 | 2,879 | 2,326 |
| Operating Income | -619 | 571 | 145 | 271 | 216 |
| Other Income | -64 | -56 | -70 | -115 | -74 |
| Pre-tax Income | -683 | 514 | 75 | 156 | 141 |
| Income Tax | 1 | 1 | 1 | 8 | N/A |
| Net Income Continuous | -684 | 513 | 74 | 148 | 141 |
| Net Income | $-684 | $513 | $74 | $148 | $141 |
| EPS Basic Total Ops | -0.09 | 0.07 | 0.01 | 0.02 | 0.02 |
| EPS Basic Continuous Ops | -0.09 | 0.07 | 0.01 | 0.02 | 0.02 |
| EPS Diluted Total Ops | -0.09 | 0.07 | 0.01 | 0.02 | 0.02 |
| EPS Diluted Continuous Ops | -0.09 | 0.07 | 0.01 | 0.02 | 0.02 |
| EBITDA(a) | $12 | $1,194 | $749 | $891 | $840 |